Swedbank AB Sells 72,852 Shares of Solventum Corporation $SOLV

Key Points

• Swedbank AB has significantly reduced its holdings in Solventum Corporation (by 61.5%), now owning 45,644 shares valued at approximately $3.46 million after selling 72,852 shares in the second quarter.
• Multiple institutional investors have increased their positions in Solventum, including Ameriprise Financial, which grew its stake by 14.8%, and Royal Bank of Canada, which increased its holdings by 31.6%.
• Solventum reported strong quarterly earnings on August 7th, with $1.69 earnings per share, surpassing analysts' expectations, along with a projected FY 2025 guidance of $5.800-5.950 EPS.

Swedbank AB decreased its holdings in Solventum Corporation (NYSE:SOLV - Free Report) by 61.5% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 45,644 shares of the company's stock after selling 72,852 shares during the quarter. Swedbank AB's holdings in Solventum were worth $3,462,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Rossby Financial LCC acquired a new stake in Solventum in the 1st quarter worth about $25,000. Strengthening Families & Communities LLC increased its holdings in Solventum by 376.8% in the 1st quarter. Strengthening Families & Communities LLC now owns 329 shares of the company's stock valued at $25,000 after buying an additional 260 shares during the period. Hara Capital LLC bought a new position in Solventum in the 1st quarter valued at about $38,000. Smartleaf Asset Management LLC increased its holdings in Solventum by 193.4% in the 1st quarter. Smartleaf Asset Management LLC now owns 534 shares of the company's stock valued at $40,000 after buying an additional 352 shares during the period. Finally, Costello Asset Management INC bought a new position in Solventum in the 1st quarter valued at about $42,000.

Analyst Ratings Changes

Several equities analysts have commented on SOLV shares. Zacks Research raised shares of Solventum from a "hold" rating to a "strong-buy" rating in a report on Monday, September 15th. Argus raised shares of Solventum from a "hold" rating to a "buy" rating and set a $90.00 target price on the stock in a report on Tuesday, July 1st. Piper Sandler reissued an "overweight" rating and issued a $94.00 target price (up from $87.00) on shares of Solventum in a report on Friday, August 8th. Wells Fargo & Company raised their price target on shares of Solventum from $79.00 to $82.00 and gave the company an "equal weight" rating in a research note on Monday, September 15th. Finally, KeyCorp initiated coverage on shares of Solventum in a research note on Friday, June 6th. They issued a "sector weight" rating on the stock. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $85.44.

Solventum Trading Up 0.1%

NYSE:SOLV traded up $0.07 during mid-day trading on Monday, hitting $73.79. 1,484,158 shares of the company's stock were exchanged, compared to its average volume of 1,045,100. The firm has a market capitalization of $12.79 billion, a P/E ratio of 13.19, a PEG ratio of 3.00 and a beta of 0.53. Solventum Corporation has a fifty-two week low of $60.70 and a fifty-two week high of $85.92. The company has a current ratio of 1.22, a quick ratio of 0.86 and a debt-to-equity ratio of 2.14. The company has a 50 day simple moving average of $72.98 and a 200-day simple moving average of $72.35.

Solventum (NYSE:SOLV - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $1.69 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.45 by $0.24. The firm had revenue of $2.16 billion for the quarter, compared to the consensus estimate of $2.12 billion. Solventum had a net margin of 4.52% and a return on equity of 29.93%. The company's revenue for the quarter was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.56 EPS. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. As a group, research analysts expect that Solventum Corporation will post 6.58 earnings per share for the current year.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.